Allscripts
Most Patients With Inherited Heart Conditions Not Getting Guideline-Backed Genetic Testing
Researchers analyzed electronic health and claims records to discover very low genetic testing rates among patients with five inherited cardiovascular conditions.
AccessDx Acquires 2bPrecise From Allscripts
Molecular lab and software firm AccessDx expects the deal to accelerate adoption of precision medicine at the point of care.
2bPrecise Takes Precision Medicine Platform to Otolaryngology Practice as it Continues to Expand
Premium
San Francisco Otolaryngology hopes that 2bPrecise's PGx technology can help manage the medication burden on older patients and improve symptoms of dementia.
2bPrecise, Q-State Biosciences Partner on Precision Medicine
The companies will build clinical-genomic datasets to serve medical practitioners at the point of care as well as inform drug development.
While large health systems develop comprehensive precision medicine strategies, smaller hospitals don't want to wait for pharmacogenomics technology.